Table 3.
Frequency of Risk Management Recommendations
| Risk Management Recommendations | N (%) |
|---|---|
| Monogenic Hereditary Related Recommendations | 597 (31.6%) |
| Genetic counseling for hereditary cardiac syndromes | 107 (5.7%) |
| Genetic counseling for hereditary cancer syndromes [26–29] | 395 (20.1%) |
| Genetic counseling for hereditary thrombophilia [30] | 165 (8.7% |
| Familial hypercholesterolemia testing [31] | 66 (3.4%) |
| Hemochromatosis iron studies and genetic testing [32] | 3 (0.2%) |
| Wilson’s disease genetic testing [33] | 11 (0.6%) |
| Alpha 1 anti-trypsinase deficiency genetic testing [34] | 11 (0.6%) |
| Familial Cancer Related Recommendations | 508 (26.9%) |
| Ovarian cancer screening discussion [35] | 32 (1.7%) |
| Breast MRI screening [5] | 58 (3.2%) |
| Breast cancer chemoprevention [36] | 109 (6%) |
| Colonoscopy screening starting age < 50 and/or more frequently [37, 38] | 241 (13.1%) |
| Common Chronic Disease Related Recommendations | 1059 (56.1%) |
| Aspirin for stroke prevention [39] | 67 (3.6%) |
| Diabetes screening | 858 (45.4%) |
| Abdominal Aortic Aneurysm screening [40, 41] | 389 (20.6%) |
| Calcium scoring CT for further cardiovascular risk stratification [4] | 11 (0.6%) |
| Lung cancer screening [42] | 45 (2.4%) |
Because participants could receive more than one recommendation, percentages in the value column do not sum to 100